Research graph
References from Overcoming Biological Barriers with Sononanomedicine: New Horizons in Oncology and Neurology. Local targets link to admitted publications; unresolved targets remain external evidence.
Nanomedicines Reshape the Tumor Microenvironment: Multidimensional Strategies from Modulating ″Barriers″ to Metabolic Intervention
10.2147/ijn.s570411 · 2026 · External reference
New opportunities and old challenges in the clinical translation of nanotheranostics
10.1038/s41578-023-00581-x · 2023 · External reference
Microvascular and stromal normalization combined with nano-immunotherapy: A synergistic strategy to overcome drug delivery barriers in solid tumors
10.1016/j.mvr.2026.104955 · 2026 · External reference
A multiphysics computational model of focused ultrasound-enhanced drug delivery using temperature-sensitive liposomes
10.1007/s10237-026-02075-5 · 2026 · External reference
The synergistic potential of mechanotherapy and sonopermeation to enhance cancer treatment effectiveness
10.1038/s44341-025-00017-3 · 2025 · External reference
Mechanical forces inducing oxaliplatin resistance in pancreatic cancer can be targeted by autophagy inhibition
10.1038/s42003-024-07268-1 · 2024 · External reference
Intratumoral fate of functional nanoparticles in response to microenvironment factor: Implications on cancer diagnosis and therapy
10.1016/j.addr.2019.06.007 · 2019 · External reference
Biomaterials tools to modulate the tumour microenvironment in immunotherapy
10.1038/s44222-022-00004-6 · 2023 · External reference
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
10.1016/j.ccell.2023.02.016 · 2023 · External reference
Biological effects of ultrasonic cavitation in cancer therapy: from physics to mechanobiology
10.1016/j.canlet.2026.218539 · 2026 · External reference
Overcoming key biological barriers to cancer drug delivery and efficacy
10.1016/j.jconrel.2017.09.016 · 2017 · External reference
Overcoming biological barriers to improve solid tumor immunotherapy
10.1007/s13346-021-00923-8 · 2021 · External reference
Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles
10.1016/j.jconrel.2021.11.024 · 2022 · External reference
Stimuli-responsive nanoplatforms for central nervous system disorders: integrating delivery, modulation, and imaging
10.1039/d5cs01323b · 2026 · External reference
Smart Ultrasound-responsive Polymers for Drug Delivery: An Overview on Advanced Stimuli-sensitive Materials and Techniques
10.2174/0115672018283792240115053302 · 2025 · External reference
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy
10.7150/thno.69682 · 2022 · External reference
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade
10.1007/s11912-024-01497-7 · 2024 · External reference
From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research
10.1016/j.addr.2024.115199 · 2024 · External reference
Programming Pluripotent Precursor Cells Derived from Xenopus Embryos to Generate Specific Tissues and Organs
10.3390/genes1030413 · 2010 · External reference
Barrier-breaking effects of ultrasonic cavitation for drug delivery and biomarker release
10.1016/j.ultsonch.2023.106346 · 2023 · External reference
Assessment of neck muscle thickness and stiffness in Chinese healthy individuals by ultrasound
10.21037/qims-2025-435 · 2025 · External reference
Ultrasonography assessments of meibomian gland as a noninvasive method of detecting changes in morphology
10.1016/j.jtos.2025.06.006 · 2025 · External reference
Focused ultrasound therapy for movement disorders
10.1016/s1474-4422(25)00210-8 · 2025 · External reference
Advanced Ultrasound Technologies for Diagnosis and Therapy
10.2967/jnumed.117.200030 · 2018 · External reference
Sub-millimetre precision of drug delivery in the brain from ultrasound-triggered nanodroplets
10.1016/j.jconrel.2021.09.014 · 2021 · External reference
Ultrasound-mediated spatial and temporal control of engineered cells in vivo
10.1038/s41467-024-51620-2 · 2024 · External reference
H-bonded organic frameworks as ultrasound-programmable delivery platform
10.1038/s41586-024-08401-0 · 2025 · External reference
The application of ultrasound-induced blood–brain barrier opening in neurology and immunology
10.1002/smll.202502699 · 2025 · External reference
Opening doors with ultrasound and microbubbles: Beating biological barriers to promote drug delivery
10.1016/j.addr.2021.02.015 · 2021 · External reference
Bio-barrier-adaptable biomimetic nanomedicines combined with ultrasound for enhanced cancer therapy
10.1038/s41392-025-02217-8 · 2025 · External reference
Acoustically triggered mechanotherapy using genetically encoded gas vesicles
10.1038/s41565-021-00971-8 · 2021 · External reference
Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity
10.1038/s41467-023-39607-x · 2023 · External reference
Liposomes as biocompatible and smart delivery systems – the current state
10.1016/j.cis.2022.102757 · 2022 · External reference
Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches
10.1016/j.cis.2023.102930 · 2023 · External reference
Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect
10.1038/s41416-022-02076-y · 2023 · External reference
Recent progress in stimuli-responsive polymeric micelles for targeted delivery of functional nanoparticles
10.1016/j.cis.2024.103206 · 2024 · External reference
Stimuli-responsive dynamic hydrogels: design, properties and tissue engineering applications
10.1039/d3mh00399j · 2023 · External reference
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
10.1016/j.addr.2019.01.005 · 2019 · External reference
In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy
10.1002/adma.202209529 · 2023 · External reference
High-intensity focused ultrasound tumor ablation: Review of ten years of clinical experience
10.1007/s11684-010-0092-8 · 2010 · External reference
Recent advances in acoustic cavitation-inducible materials for cancer sonotheranostics
10.1039/d5nr05210f · 2026 · External reference
Progress of research in the application of ultrasound technology for the treatment of Alzheimer’s disease
10.4103/nrr.nrr-d-24-00539 · 2025 · External reference
Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms
10.1016/j.addr.2013.11.008 · 2014 · External reference
Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications
10.1016/j.jconrel.2016.09.026 · 2016 · External reference
Ultrasound-responsive nanocarriers for cancer therapy: physiochemical features-directed design
10.1016/j.jconrel.2025.114353 · 2025 · External reference
A T-Cell Inspired Sonoporation System Enhances Low-Dose X-Ray-Mediated Pyroptosis and Radioimmunotherapy Efficacy by Restoring Gasdermin-E Expression
10.1002/adma.202401384 · 2024 · External reference
Cell-cycle dependent nuclear gene delivery enhances the effects of E-cadherin against tumor invasion and metastasis
10.1038/s41392-023-01398-4 · 2023 · External reference
Ultrasound-mediated blood–brain barrier opening: An effective drug delivery system for theranostics of brain diseases
10.1016/j.addr.2022.114539 · 2022 · External reference
High-Concentrated Reactive Oxygen Species from Chiral Thyroxine for Piezocatalytic Antitumor Therapy
10.1002/adfm.202519435 · 2026 · External reference
Remote-Controllable Immune-Priming Spot Formation Via Nanocomplexed Hydrogel-Assisted Histotripsy: Immunoasis
10.1002/adma.202518245 · 2026 · External reference
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial
10.1016/s1470-2045(23)00112-2 · 2023 · External reference
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
10.1038/s41467-024-45818-7 · 2024 · External reference
Safety and feasibility of repeated and transient blood–brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma
10.1158/1078-0432.ccr-18-3643 · 2019 · External reference
A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer
10.1016/j.jconrel.2016.10.007 · 2016 · External reference
Clinical study of ultrasound and microbubbles for enhancing chemotherapeutic sensitivity of malignant tumors in digestive system
10.21147/j.issn.1000-9604.2018.05.09 · 2018 · External reference
The characterization of acoustic cavitation bubbles – An overview
10.1016/j.ultsonch.2010.11.016 · 2011 · External reference
Multifunctional sonosensitizers in sonodynamic cancer therapy
10.1039/c9cs00648f · 2020 · External reference
Biodegradable Nanoprodrugs: “Delivering” ROS to Cancer Cells for Molecular Dynamic Therapy
10.1002/adma.201904011 · 2020 · External reference
Ultrasound-activatable transition metal complexes to potentiate sonodynamic therapy
10.1039/d5sc06387f · 2025 · External reference
Bio-effects and safety of low-intensity, low-frequency ultrasonic exposure
10.1016/j.pbiomolbio.2012.01.004 · 2012 · External reference
Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound
10.1073/pnas.1700790114 · 2017 · External reference
Ultrasound-mediated micellar drug delivery
10.3109/02656736.2012.665567 · 2012 · External reference
Low-boiling-point perfluorocarbon nanodroplets for adaptable ultrasound-induced blood-brain barrier opening
10.1016/j.jconrel.2024.10.023 · 2024 · External reference
Closed-loop trans-skull ultrasound hyperthermia leads to improved drug delivery from thermosensitive drugs and promotes changes in vascular transport dynamics in brain tumors
10.7150/thno.54630 · 2021 · External reference
Large-Volume Focused-Ultrasound Mild Hyperthermia for Improving Blood-Brain Tumor Barrier Permeability Application
10.3390/pharmaceutics14102012 · 2022 · External reference
Regulation of the brain tumor microenvironment by focused ultrasound
10.1016/j.omton.2025.200994 · 2025 · External reference
Minimally invasive therapeutic ultrasound: Ultrasound-guided ultrasound ablation in neuro-oncology
10.1016/j.ultras.2020.106210 · 2020 · External reference
Bioeffects Committee of the American Institute of Ultrasound in, M. Overview of Therapeutic Ultrasound Applications and Safety Considerations
10.7863/jum.2012.31.4.623 · 2012 · External reference
Blood–brain barrier opening in alzheimer’s disease using MR-guided focused ultrasound
10.1038/s41467-018-04529-6 · 2018 · External reference
Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies
10.1021/acs.bioconjchem.1c00437 · 2022 · External reference
Progress in application of nanomedicines for enhancing cancer sono-immunotherapy
10.1016/j.ultsonch.2024.107105 · 2024 · External reference
Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape
10.4049/jimmunol.1500541 · 2016 · External reference
Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment
10.3390/pharmaceutics13081295 · 2021 · External reference
Synergistic checkpoint-blockade and radiotherapy–radiodynamic therapy via an immunomodulatory nanoscale metal–organic framework
10.1038/s41551-022-00846-w · 2022 · External reference
Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
10.1038/s41467-023-38796-9 · 2023 · External reference
Nanoparticles with ultrasound-induced afterglow luminescence for tumour-specific theranostics
10.1038/s41551-022-00978-z · 2023 · External reference
Bimetal-Biligand Frameworks for Spatiotemporal Nitric Oxide-Enhanced Sono-Immunotherapy
10.1002/adma.202408242 · 2024 · External reference
Immunogenic cell stress and death
10.1038/s41590-022-01132-2 · 2022 · External reference
Responsive biomaterials: optimizing control of cancer immunotherapy
10.1038/s41578-023-00617-2 · 2024 · External reference
Understanding Heterogeneities in Quantum Materials
10.1002/adma.202106909 · 2023 · External reference
Clinical development and potential of photothermal and photodynamic therapies for cancer
10.1038/s41571-020-0410-2 · 2020 · External reference
Structure-property relationships of main-group element phthalocyanines in photo/sono-driven cancer therapy
10.1016/j.ccr.2025.216969 · 2025 · External reference
Current roles of metals in arming sonodynamic cancer therapy
10.1016/j.ccr.2024.216169 · 2024 · External reference
Intracellular Photocatalytic NADH/NAD(P)H Oxidation for Cancer Drug Development
10.1021/jacs.4c18328 · 2025 · External reference
Self-Assembled Ruthenium Complexes With Sonobleaching Ligand for Enhanced Tumor Penetration and Immunogenic Sonotherapy
10.1002/adma.202523608 · 2026 · External reference
PEGylated Ultrasmall Iron Oxide Nanoparticles as MRI Contrast Agents for Vascular Imaging and Real-Time Monitoring
10.1021/acsnano.4c13356 · 2025 · External reference
Enhancing cancer immunotherapy with nanomedicine
10.1038/s41577-019-0269-6 · 2020 · External reference
Delivery technologies for cancer immunotherapy
10.1038/s41573-018-0006-z · 2019 · External reference
Recent Advances in Engineered Materials for Immunotherapy-Involved Combination Cancer Therapy
10.1002/adma.202007630 · 2021 · External reference
Lipid bilayer-based biological nanoplatforms for sonodynamic cancer therapy
10.1016/j.addr.2023.115110 · 2023 · External reference
Advanced disease therapeutics using engineered living drug delivery systems
10.1039/d4nr05298f · 2025 · External reference
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
10.1016/j.addr.2021.113851 · 2021 · External reference
Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H2O2 and Catalase for Enhanced Radio-Immunotherapy of Cancer
10.1021/acs.nanolett.8b02720 · 2018 · External reference
Supercritical Fluids: An Innovative Strategy for Drug Development
10.3390/bioengineering11080788 · 2024 · External reference
Ultrasound-responsive microbubbles and nanodroplets: a pathway to targeted drug delivery
10.1016/j.addr.2023.115178 · 2024 · External reference
Atomic force microscopy-based mechanobiology
10.1038/s42254-018-0001-7 · 2019 · External reference
Tailoring the size of ultrasound responsive lipid-shelled nanodroplets by varying production parameters and environmental conditions
10.1016/j.ultsonch.2021.105482 · 2021 · External reference
Biomimetic liposomal nanovesicles remodel the tumor immune microenvironment to augment sono-immunotherapy
10.1016/j.jconrel.2025.113830 · 2025 · External reference
Sonoporation enhances liposome accumulation and penetration in tumors with low EPR
10.1016/j.jconrel.2016.02.021 · 2016 · External reference
Focused ultrasound-mediated nanocarrier delivery across the blood-brain barrier for neurodegenerative diseases
10.1016/j.biopha.2026.119622 · 2026 · External reference
Ultrasound-mediated blood–brain barrier disruption for targeted drug delivery in the central nervous system
10.1016/j.addr.2014.01.008 · 2014 · External reference
Ultrasound-responsive polymer-based drug delivery systems
10.1007/s13346-021-00963-0 · 2021 · External reference
Polymeric materials for ultrasound imaging and therapy
10.1039/d3sc04339h · 2023 · External reference
Oxygen-generating polymer vesicles for enhanced sonodynamic tumor therapy
10.1016/j.jconrel.2022.12.023 · 2023 · External reference
Supramolecularly-Cross-Linked Nanogel Assemblies for On-Demand, Ultrasound-Triggered Chemotherapy
10.1021/acs.biomac.3c01432 · 2024 · External reference
Tuning the Elasticity of Polymersomes for Brain Tumor Targeting
10.1002/advs.202102001 · 2021 · External reference
A tumor-targeting nano-adjuvant for in situ vaccine based on ultrasound therapy
10.1002/agt2.504 · 2024 · External reference
Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation
10.1016/j.jconrel.2015.11.009 · 2016 · External reference
Redox/ultrasound dual stimuli-responsive nanogel for precisely controllable drug release
10.1039/c8nj00392k · 2018 · External reference
Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact
10.1038/s44222-024-00203-3 · 2024 · External reference
Mechanisms and barriers in nanomedicine: progress in the field and future directions
10.1021/acsnano.4c00182 · 2024 · External reference
Specific endothelial cells govern nanoparticle entry into solid tumors
10.1021/acsnano.1c04510 · 2021 · External reference
Monitoring EPR effect dynamics during nanotaxane treatment with theranostic polymeric micelles
10.1002/advs.202103745 · 2022 · External reference
Efficient ultrasound-mediated drug delivery to orthotopic liver tumors – direct comparison of doxorubicin-loaded nanobubbles and microbubbles
10.1016/j.jconrel.2024.01.028 · 2024 · External reference
Bio-Barrier-adaptable biomimetic nanomedicines combined with ultrasound for enhanced cancer therapy
10.1038/s41392-025-02217-8 · 2025 · External reference
Cyclic jetting enables microbubble-mediated drug delivery
10.1038/s41567-025-02785-0 · 2025 · External reference
Drug transport kinetics of intravascular triggered drug delivery systems
10.1038/s42003-021-02428-z · 2021 · External reference
Ultrasound-responsive liposomes for targeted drug delivery combined with focused ultrasound
10.3390/pharmaceutics14071314 · 2022 · External reference
Focused ultrasound-triggered doxorubicin liposomes reshape tumor microenvironment to boost checkpoint depletion in triple-negative breast cancer model
10.1016/j.jconrel.2025.114389 · 2025 · External reference
Effect of microbubble-assisted gemcitabine delivery with repeated ultrasound exposure in a pancreatic cancer organ-on-a-chip model
10.1038/s41598-025-30612-2 · 2025 · External reference
An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy
10.1126/sciadv.adg5964 · 2023 · External reference
Ultrasound-responsive nutlin-loaded nanoparticles for combined chemotherapy and piezoelectric treatment of glioblastoma cells
10.1016/j.actbio.2021.04.005 · 2022 · External reference
Engineering photodynamics for treatment, priming and imaging
10.1038/s44222-024-00196-z · 2024 · External reference
Recent advances in strategies for addressing hypoxia in tumor photodynamic therapy
10.3390/biom12010081 · 2022 · External reference
Nanoparticles with Ultrasound-induced afterglow luminescence for tumour-specific theranostics
10.1038/s41551-022-00978-z · 2023 · External reference
Ultrasmall barium titanate nanoparticles for highly efficient hypoxic tumor therapy via ultrasound triggered piezocatalysis and water splitting
10.1021/acsnano.1c00616 · 2021 · External reference
Near-infrared phosphorescent carbon dots for sonodynamic precision tumor therapy
10.1038/s41467-022-33474-8 · 2022 · External reference
Sonophoto-activable artificial cupreous peroxidases for controllable and redox-targeted ablation of primary and metastatic cancers
10.1016/j.celbio.2026.100348 · 2026 · External reference
GSH-Activated Porphyrin Sonosensitizer Prodrug for Fluorescence Imaging-Guided Cancer Sonodynamic Therapy
10.1002/adfm.202300348 · 2023 · External reference
Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions
10.1016/j.fmre.2022.06.020 · 2025 · External reference
Zn/Pt dual-site single-atom driven difunctional superimposition-augmented sonosensitizer for sonodynamic therapy boosted ferroptosis of cancer
10.1038/s41467-024-53488-8 · 2024 · External reference
Ultrasound-Triggered Localized Surface Plasmon Resonance Enhances Electron Transfer for Melanoma Sonodynamic Therapy
10.1021/acsnano.6c04010 · 2026 · External reference
Collagenase-loaded H-TiO2 nanoparticles enhance ultrasound imaging-guided sonodynamic therapy in a pancreatic carcinoma xenograft model via digesting stromal barriers
10.1021/acsami.2c08951 · 2022 · External reference
CAFs targeted ultrasound-responsive nanodroplets loaded V9302 and GLULsiRNA to inhibit melanoma growth via glutamine metabolic reprogramming and tumor microenvironment remodeling
10.1186/s12951-023-01979-z · 2023 · External reference
Targeting Vascular Destruction by Sonosensitizer-Free Sonocatalytic Nanomissiles Instigates Thrombus Aggregation and Nutrition Deprivation to Starve Pancreatic Cancer
10.1002/adfm.202315394 · 2024 · External reference
Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity
10.1038/s41467-023-42509-7 · 2023 · External reference
Engineered extracellular vesicle-based sonotheranostics for dual stimuli-sensitive drug release and photoacoustic imaging-guided chemo-sonodynamic cancer therapy
10.7150/thno.65516 · 2022 · External reference
A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy
10.7150/thno.64862 · 2022 · External reference
High-Entropy Oxide-Phosphomolybdic Acid Ultrathin Nanoleaves with Lattice Strain and Periodic Heterostructures for Enhanced Synthetic Catalytic/Sonodynamic/Immune Therapy
10.1021/acsnano.6c00143 · 2026 · External reference
Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation
10.7150/thno.62572 · 2021 · External reference
High intensity focused ultrasound-responsive and ultrastable cerasomal perfluorocarbon nanodroplets for alleviating tumor multidrug resistance and epithelial–mesenchymal transition
10.1021/acsnano.0c07287 · 2020 · External reference
A Sonosensitizing Nanoshuttle for Synergistic Hypoxia Relief and Immune Activation To Strengthen Sonodynamic Immunotherapy Against Triple-Negative Breast Cancer
10.1021/acsnano.5c16697 · 2026 · External reference
A Tumor Microenvironment-Responsive Self-Oxygenating Nanoplatform for Dual-Enhanced Cuproptosis and Sonodynamic Synergistic Immunotherapy
10.1021/acsnano.5c12847 · 2025 · External reference
In-situ TiO2-x decoration of titanium carbide MXene for photo/sono-responsive antitumor theranostics
10.1186/s12951-022-01253-8 · 2022 · External reference
Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity
10.1038/s41467-023-42509-7 · 2023 · External reference
Ultrasmall Alloy Nanozyme for Ultrasound- and Near-Infrared Light-Promoted Tumor Ablation
10.1021/acsnano.1c01830 · 2021 · External reference
Biomimetic nanoprobe-augmented triple therapy with photothermal, sonodynamic and checkpoint blockade inhibits tumor growth and metastasis
10.1186/s12951-022-01287-y · 2022 · External reference
Endogenous and exogeneous stimuli-triggered reactive oxygen species evoke long-lived carbon monoxide to fight against lung cancer
10.1186/s12951-024-02688-x · 2024 · External reference
First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound
10.1186/2050-5736-2-17 · 2014 · External reference
Perfluorohexane nanodroplet-assisted mechanical high intensity focused ultrasound cavitation: a strategy for hepatocellular carcinoma treatment
10.1016/j.actbio.2025.01.061 · 2025 · External reference
The role of acoustic parameters in droplet vaporization of perfluoropentane nanodroplets for In Vivo applications
10.1021/acsami.5c05638 · 2025 · External reference
Neutrophil-mediated clinical nanodrug for treatment of residual tumor after focused ultrasound ablation
10.1186/s12951-021-01087-w · 2021 · External reference
High intensity focused ultrasound-driven nanomotor for effective ferroptosis-immunotherapy of TNBC
10.1002/advs.202305546 · 2024 · External reference
Immunologic tumor microenvironment modulators for turning cold tumors hot
10.1002/cac2.12539 · 2024 · External reference
Ultrasound-enhanced Pt-coordinated polymer immunopotentiators and heterogenic fusion membrane-based multifunctional tumor vaccine nanoplatforms for melanoma treatment
10.1038/s41392-025-02355-z · 2025 · External reference
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
10.1158/2326-6066.cir-20-0586 · 2022 · External reference
Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
10.1038/s41591-023-02345-0 · 2023 · External reference
Intraparticle Double-Scattering-Decoded Sonogenetics for Augmenting Immune Checkpoint Blockade and CAR-T Therapy
10.1002/advs.202203106 · 2022 · External reference
Multichannel Immune Nanoregulators Suppress Lactic Acid Metabolism and Lactic Acid-Shaped Acidic Microenvironment to Uproot Anti-Tumor Immunosuppression
10.1002/adma.202512230 · 2026 · External reference
Ultrasound-augmented mitochondrial calcium ion overload by calcium nanomodulator to induce immunogenic cell death
10.1021/acs.nanolett.0c04778 · 2021 · External reference
Ultrasound-responsive lipid nanosonosensitizers with size reduction and NO release: synergistic sonodynamic-chemo-immunotherapy for pancreatic tumors
10.1002/anie.202507388 · 2025 · External reference
Immunosonodynamic Therapy Designed with Activatable Sonosensitizer and Immune Stimulant Imiquimod
10.1021/acsnano.2c03395 · 2022 · External reference
Sono-Driven STING Activation using Semiconducting Polymeric Nanoagonists for Precision Sono-Immunotherapy of Head and Neck Squamous Cell Carcinoma
10.1002/adma.202300854 · 2023 · External reference
Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy
10.1186/s12951-022-01453-2 · 2022 · External reference
Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy
10.1136/jitc-2022-006226 · 2023 · External reference
Ultrasound-triggered and glycosylation inhibition-enhanced tumor piezocatalytic immunotherapy
10.1038/s41467-024-53392-1 · 2024 · External reference
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
10.1038/s41568-019-0205-x · 2020 · External reference
Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints
10.3390/ijms23031711 · 2022 · External reference
Strategies to Improve Drug Delivery Across the Blood–Brain Barrier for Glioblastoma
10.1007/s11910-024-01338-x · 2024 · External reference
An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain
10.1016/j.jconrel.2019.10.044 · 2019 · External reference
Ultrasound-mediated blood-brain barrier opening: an effective drug delivery system for theranostics of brain diseases
10.1016/j.addr.2022.114539 · 2022 · External reference
Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor
10.3390/pharmaceutics13010015 · 2021 · External reference
The road ahead to successful BBB opening and drug-delivery with focused ultrasound
10.1016/j.jconrel.2024.07.006 · 2024 · External reference
Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model
10.1073/pnas.1713328114 · 2017 · External reference
Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood–brain barrier opening
10.1038/s41598-020-75253-9 · 2020 · External reference
Focused ultrasound-mediated enhancement of blood–brain barrier permeability for brain tumor treatment: a systematic review of clinical trials
10.1007/s11060-024-04795-z · 2024 · External reference
Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial
10.1016/s1470-2045(23)00112-2 · 2023 · External reference
Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas
10.1038/s41467-024-48326-w · 2024 · External reference
Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma
10.1016/j.jconrel.2025.114018 · 2025 · External reference
Drug delivery to the central nervous system
10.1038/s41578-021-00394-w · 2022 · External reference
The blood-brain barrier: physiology and strategies for drug delivery
10.1016/j.addr.2019.11.009 · 2020 · External reference
Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases
10.1016/j.addr.2024.115323 · 2024 · External reference
Transcranial blood-brain barrier opening in alzheimer’s disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping
10.7150/thno.94206 · 2024 · External reference
Current clinical investigations of focused ultrasound blood-brain barrier disruption: a review
10.1016/j.neurot.2024.e00352 · 2024 · External reference
A sporadic Alzheimer’s blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies
10.7150/thno.72685 · 2022 · External reference
Aducanumab delivery via focused ultrasound-induced transient blood–brain barrier opening in vivo
10.1038/s41598-025-02412-1 · 2025 · External reference
A comparative study of the effects of aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of alzheimer disease
10.1186/s13195-021-00809-4 · 2021 · External reference
Unilateral Focused Ultrasound-Induced Blood-Brain Barrier Opening Reduces Phosphorylated Tau from The rTg4510 Mouse Model
10.7150/thno.28717 · 2019 · External reference
Effects of blood-brain barrier opening using ultrasound on tauopathies: a systematic review
10.1016/j.jconrel.2025.01.056 · 2025 · External reference
Focused ultrasound on the substantia nigra enables safe neurotensin-polyplex nanoparticle-mediated gene delivery to dopaminergic neurons intranasally and by blood circulation
10.1186/s11671-024-04005-9 · 2024 · External reference
Microbubble drug conjugate and focused ultrasound blood brain barrier delivery of AAV-2 SIRT-3
10.1080/10717544.2022.2035855 · 2022 · External reference
Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy
10.1016/j.jconrel.2024.11.074 · 2025 · External reference
Liposome delivery to the brain with rapid short-pulses of focused ultrasound and microbubbles
10.1016/j.jconrel.2021.12.005 · 2022 · External reference
Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity
10.7150/thno.52436 · 2021 · External reference
Low intensity ultrasound-facilitated exosome delivery promotes hippocampal neurogenesis in alzheimer’s disease
10.1016/j.brs.2025.103015 · 2026 · External reference
Nanobubble-actuated ultrasound neuromodulation for selectively shaping behavior in mice
10.1038/s41467-024-46461-y · 2024 · External reference
Accurate neurotransmitter release by ultrasound-responsive nanomaterials for alleviating L-DOPA-induced dyskinesia in parkinson’s disease
10.1002/adhm.202501765 · 2025 · External reference
Neuromodulation by nanozymes and ultrasound during alzheimer’s disease management
10.1186/s12951-024-02406-7 · 2024 · External reference
Sono-piezoelectric cues regulate neuroinflammatory reflex-arc-mediated α7nAChR-P2RX7 axis to dampen osteoarthritis-correlated pain with osteoarthritis attenuation
10.7150/thno.125686 · 2026 · External reference
Translating ultrasound-mediated drug delivery technologies for CNS applications
10.1016/j.addr.2024.115274 · 2024 · External reference
Spinal cord injury: molecular mechanisms and therapeutic interventions
10.1038/s41392-023-01477-6 · 2023 · External reference
Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration
10.1186/s12974-021-02337-2 · 2021 · External reference
Potential applications of focused ultrasound for spinal cord diseases: a narrative review of preclinical studies
10.1016/j.bas.2025.104298 · 2025 · External reference
Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery
10.1016/j.ultrasmedbio.2020.01.002 · 2020 · External reference
Magnetic resonance imaging-guided focused ultrasound to increase localized blood-spinal cord barrier permeability
10.4103/1673-5374.221162 · 2017 · External reference
Disruption of the blood-spinal cord barrier using low-intensity focused ultrasound in a rat model
10.3791/65113 · 2023 · External reference
Focused ultrasound-induced blood–spinal cord barrier opening using short-burst phase-keying exposures in rats: a parameter study
10.1016/j.ultrasmedbio.2021.03.007 · 2021 · External reference
A porcine model of transvertebral ultrasound and microbubble-mediated blood-spinal cord barrier opening
10.7150/thno.46821 · 2020 · External reference
Characterization of ultrasound-mediated delivery of trastuzumab to normal and pathologic spinal cord tissue
10.1038/s41598-021-83874-x · 2021 · External reference
Nerve growth factor delivery by ultrasound-mediated nanobubble destruction as a treatment for acute spinal cord injury in rats
10.2147/ijn.s128848 · 2017 · External reference
Noninvasive, targeted gene therapy for acute spinal cord injury using LIFU-mediated BDNF-loaded cationic nanobubble destruction
10.1016/j.bbrc.2018.01.123 · 2018 · External reference
Spatiotemporal-controlled ultrasound-driven Li-PDA@ZnO nanoparticles promote neural stem cell differentiation synergy with biohydrogel repair spinal cord injury
10.1016/j.bioactmat.2025.07.050 · 2026 · External reference
Biomimetic piezoelectric hydrogel system for energy metabolism reprogramming in spinal cord injury repair
10.7150/thno.108329 · 2025 · External reference
Imaging-guided precision hyperthermia with magnetic nanoparticles
10.1038/s44222-024-00257-3 · 2025 · External reference
Safety evaluation of a clinical focused ultrasound system for neuronavigation guided blood-brain barrier opening in non-human primates
10.1038/s41598-021-94188-3 · 2021 · External reference
Disrupting the blood–brain barrier by focused ultrasound induces sterile inflammation
10.1073/pnas.1614777114 · 2017 · External reference
Therapeutic efficacy of nanoparticles and routes of administration
10.1186/s40824-019-0166-x · 2019 · External reference
GSH-Activated Porphyrin Sonosensitizer Prodrug for Fluorescence Imaging-Guided Cancer Sonodynamic Therapy
10.1002/adfm.202300348 · ExternalCitation · doi-reference
Targeting Vascular Destruction by Sonosensitizer-Free Sonocatalytic Nanomissiles Instigates Thrombus Aggregation and Nutrition Deprivation to Starve Pancreatic Cancer
10.1002/adfm.202315394 · ExternalCitation · doi-reference
High-Concentrated Reactive Oxygen Species from Chiral Thyroxine for Piezocatalytic Antitumor Therapy
10.1002/adfm.202519435 · ExternalCitation · doi-reference
Accurate neurotransmitter release by ultrasound-responsive nanomaterials for alleviating L-DOPA-induced dyskinesia in parkinson’s disease
10.1002/adhm.202501765 · ExternalCitation · doi-reference
Biodegradable Nanoprodrugs: “Delivering” ROS to Cancer Cells for Molecular Dynamic Therapy
10.1002/adma.201904011 · ExternalCitation · doi-reference
Recent Advances in Engineered Materials for Immunotherapy-Involved Combination Cancer Therapy
10.1002/adma.202007630 · ExternalCitation · doi-reference
Understanding Heterogeneities in Quantum Materials
10.1002/adma.202106909 · ExternalCitation · doi-reference
In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy
10.1002/adma.202209529 · ExternalCitation · doi-reference
Sono-Driven STING Activation using Semiconducting Polymeric Nanoagonists for Precision Sono-Immunotherapy of Head and Neck Squamous Cell Carcinoma
10.1002/adma.202300854 · ExternalCitation · doi-reference
A T-Cell Inspired Sonoporation System Enhances Low-Dose X-Ray-Mediated Pyroptosis and Radioimmunotherapy Efficacy by Restoring Gasdermin-E Expression
10.1002/adma.202401384 · ExternalCitation · doi-reference
Bimetal-Biligand Frameworks for Spatiotemporal Nitric Oxide-Enhanced Sono-Immunotherapy
10.1002/adma.202408242 · ExternalCitation · doi-reference
Multichannel Immune Nanoregulators Suppress Lactic Acid Metabolism and Lactic Acid-Shaped Acidic Microenvironment to Uproot Anti-Tumor Immunosuppression
10.1002/adma.202512230 · ExternalCitation · doi-reference
Remote-Controllable Immune-Priming Spot Formation Via Nanocomplexed Hydrogel-Assisted Histotripsy: Immunoasis
10.1002/adma.202518245 · ExternalCitation · doi-reference
Self-Assembled Ruthenium Complexes With Sonobleaching Ligand for Enhanced Tumor Penetration and Immunogenic Sonotherapy
10.1002/adma.202523608 · ExternalCitation · doi-reference
Tuning the Elasticity of Polymersomes for Brain Tumor Targeting
10.1002/advs.202102001 · ExternalCitation · doi-reference
Monitoring EPR effect dynamics during nanotaxane treatment with theranostic polymeric micelles
10.1002/advs.202103745 · ExternalCitation · doi-reference
Intraparticle Double-Scattering-Decoded Sonogenetics for Augmenting Immune Checkpoint Blockade and CAR-T Therapy
10.1002/advs.202203106 · ExternalCitation · doi-reference
High intensity focused ultrasound-driven nanomotor for effective ferroptosis-immunotherapy of TNBC
10.1002/advs.202305546 · ExternalCitation · doi-reference
A tumor-targeting nano-adjuvant for in situ vaccine based on ultrasound therapy
10.1002/agt2.504 · ExternalCitation · doi-reference
Ultrasound-responsive lipid nanosonosensitizers with size reduction and NO release: synergistic sonodynamic-chemo-immunotherapy for pancreatic tumors
10.1002/anie.202507388 · ExternalCitation · doi-reference
Immunologic tumor microenvironment modulators for turning cold tumors hot
10.1002/cac2.12539 · ExternalCitation · doi-reference
The application of ultrasound-induced blood–brain barrier opening in neurology and immunology
10.1002/smll.202502699 · ExternalCitation · doi-reference
A multiphysics computational model of focused ultrasound-enhanced drug delivery using temperature-sensitive liposomes
10.1007/s10237-026-02075-5 · ExternalCitation · doi-reference
Focused ultrasound-mediated enhancement of blood–brain barrier permeability for brain tumor treatment: a systematic review of clinical trials
10.1007/s11060-024-04795-z · ExternalCitation · doi-reference
High-intensity focused ultrasound tumor ablation: Review of ten years of clinical experience
10.1007/s11684-010-0092-8 · ExternalCitation · doi-reference
Strategies to Improve Drug Delivery Across the Blood–Brain Barrier for Glioblastoma
10.1007/s11910-024-01338-x · ExternalCitation · doi-reference
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade
10.1007/s11912-024-01497-7 · ExternalCitation · doi-reference
Overcoming biological barriers to improve solid tumor immunotherapy
10.1007/s13346-021-00923-8 · ExternalCitation · doi-reference
Ultrasound-responsive polymer-based drug delivery systems
10.1007/s13346-021-00963-0 · ExternalCitation · doi-reference
Ultrasound-responsive nutlin-loaded nanoparticles for combined chemotherapy and piezoelectric treatment of glioblastoma cells
10.1016/j.actbio.2021.04.005 · ExternalCitation · doi-reference
Perfluorohexane nanodroplet-assisted mechanical high intensity focused ultrasound cavitation: a strategy for hepatocellular carcinoma treatment
10.1016/j.actbio.2025.01.061 · ExternalCitation · doi-reference
Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms
10.1016/j.addr.2013.11.008 · ExternalCitation · doi-reference
Ultrasound-mediated blood–brain barrier disruption for targeted drug delivery in the central nervous system
10.1016/j.addr.2014.01.008 · ExternalCitation · doi-reference
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
10.1016/j.addr.2019.01.005 · ExternalCitation · doi-reference
Intratumoral fate of functional nanoparticles in response to microenvironment factor: Implications on cancer diagnosis and therapy
10.1016/j.addr.2019.06.007 · ExternalCitation · doi-reference
The blood-brain barrier: physiology and strategies for drug delivery
10.1016/j.addr.2019.11.009 · ExternalCitation · doi-reference
Opening doors with ultrasound and microbubbles: Beating biological barriers to promote drug delivery
10.1016/j.addr.2021.02.015 · ExternalCitation · doi-reference
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
10.1016/j.addr.2021.113851 · ExternalCitation · doi-reference
Ultrasound-mediated blood-brain barrier opening: an effective drug delivery system for theranostics of brain diseases
10.1016/j.addr.2022.114539 · ExternalCitation · doi-reference
Lipid bilayer-based biological nanoplatforms for sonodynamic cancer therapy
10.1016/j.addr.2023.115110 · ExternalCitation · doi-reference
Ultrasound-responsive microbubbles and nanodroplets: a pathway to targeted drug delivery
10.1016/j.addr.2023.115178 · ExternalCitation · doi-reference
From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research
10.1016/j.addr.2024.115199 · ExternalCitation · doi-reference
Translating ultrasound-mediated drug delivery technologies for CNS applications
10.1016/j.addr.2024.115274 · ExternalCitation · doi-reference
Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases
10.1016/j.addr.2024.115323 · ExternalCitation · doi-reference
Potential applications of focused ultrasound for spinal cord diseases: a narrative review of preclinical studies
10.1016/j.bas.2025.104298 · ExternalCitation · doi-reference
Noninvasive, targeted gene therapy for acute spinal cord injury using LIFU-mediated BDNF-loaded cationic nanobubble destruction
10.1016/j.bbrc.2018.01.123 · ExternalCitation · doi-reference
Spatiotemporal-controlled ultrasound-driven Li-PDA@ZnO nanoparticles promote neural stem cell differentiation synergy with biohydrogel repair spinal cord injury
10.1016/j.bioactmat.2025.07.050 · ExternalCitation · doi-reference
Focused ultrasound-mediated nanocarrier delivery across the blood-brain barrier for neurodegenerative diseases
10.1016/j.biopha.2026.119622 · ExternalCitation · doi-reference
Low intensity ultrasound-facilitated exosome delivery promotes hippocampal neurogenesis in alzheimer’s disease
10.1016/j.brs.2025.103015 · ExternalCitation · doi-reference
Biological effects of ultrasonic cavitation in cancer therapy: from physics to mechanobiology
10.1016/j.canlet.2026.218539 · ExternalCitation · doi-reference
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
10.1016/j.ccell.2023.02.016 · ExternalCitation · doi-reference
Current roles of metals in arming sonodynamic cancer therapy
10.1016/j.ccr.2024.216169 · ExternalCitation · doi-reference
Structure-property relationships of main-group element phthalocyanines in photo/sono-driven cancer therapy
10.1016/j.ccr.2025.216969 · ExternalCitation · doi-reference
Sonophoto-activable artificial cupreous peroxidases for controllable and redox-targeted ablation of primary and metastatic cancers
10.1016/j.celbio.2026.100348 · ExternalCitation · doi-reference
Liposomes as biocompatible and smart delivery systems – the current state
10.1016/j.cis.2022.102757 · ExternalCitation · doi-reference
Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches
10.1016/j.cis.2023.102930 · ExternalCitation · doi-reference
Recent progress in stimuli-responsive polymeric micelles for targeted delivery of functional nanoparticles
10.1016/j.cis.2024.103206 · ExternalCitation · doi-reference
Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions
10.1016/j.fmre.2022.06.020 · ExternalCitation · doi-reference
Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation
10.1016/j.jconrel.2015.11.009 · ExternalCitation · doi-reference
Sonoporation enhances liposome accumulation and penetration in tumors with low EPR
10.1016/j.jconrel.2016.02.021 · ExternalCitation · doi-reference
Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications
10.1016/j.jconrel.2016.09.026 · ExternalCitation · doi-reference
A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer
10.1016/j.jconrel.2016.10.007 · ExternalCitation · doi-reference
Overcoming key biological barriers to cancer drug delivery and efficacy
10.1016/j.jconrel.2017.09.016 · ExternalCitation · doi-reference
An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain
10.1016/j.jconrel.2019.10.044 · ExternalCitation · doi-reference
Sub-millimetre precision of drug delivery in the brain from ultrasound-triggered nanodroplets
10.1016/j.jconrel.2021.09.014 · ExternalCitation · doi-reference
Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles
10.1016/j.jconrel.2021.11.024 · ExternalCitation · doi-reference
Liposome delivery to the brain with rapid short-pulses of focused ultrasound and microbubbles
10.1016/j.jconrel.2021.12.005 · ExternalCitation · doi-reference
Oxygen-generating polymer vesicles for enhanced sonodynamic tumor therapy
10.1016/j.jconrel.2022.12.023 · ExternalCitation · doi-reference
Efficient ultrasound-mediated drug delivery to orthotopic liver tumors – direct comparison of doxorubicin-loaded nanobubbles and microbubbles
10.1016/j.jconrel.2024.01.028 · ExternalCitation · doi-reference
The road ahead to successful BBB opening and drug-delivery with focused ultrasound
10.1016/j.jconrel.2024.07.006 · ExternalCitation · doi-reference
Low-boiling-point perfluorocarbon nanodroplets for adaptable ultrasound-induced blood-brain barrier opening
10.1016/j.jconrel.2024.10.023 · ExternalCitation · doi-reference
Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy
10.1016/j.jconrel.2024.11.074 · ExternalCitation · doi-reference
Effects of blood-brain barrier opening using ultrasound on tauopathies: a systematic review
10.1016/j.jconrel.2025.01.056 · ExternalCitation · doi-reference
Biomimetic liposomal nanovesicles remodel the tumor immune microenvironment to augment sono-immunotherapy
10.1016/j.jconrel.2025.113830 · ExternalCitation · doi-reference
Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma
10.1016/j.jconrel.2025.114018 · ExternalCitation · doi-reference
Ultrasound-responsive nanocarriers for cancer therapy: physiochemical features-directed design
10.1016/j.jconrel.2025.114353 · ExternalCitation · doi-reference
Focused ultrasound-triggered doxorubicin liposomes reshape tumor microenvironment to boost checkpoint depletion in triple-negative breast cancer model
10.1016/j.jconrel.2025.114389 · ExternalCitation · doi-reference
Ultrasonography assessments of meibomian gland as a noninvasive method of detecting changes in morphology
10.1016/j.jtos.2025.06.006 · ExternalCitation · doi-reference
Microvascular and stromal normalization combined with nano-immunotherapy: A synergistic strategy to overcome drug delivery barriers in solid tumors
10.1016/j.mvr.2026.104955 · ExternalCitation · doi-reference
Current clinical investigations of focused ultrasound blood-brain barrier disruption: a review
10.1016/j.neurot.2024.e00352 · ExternalCitation · doi-reference
Regulation of the brain tumor microenvironment by focused ultrasound
10.1016/j.omton.2025.200994 · ExternalCitation · doi-reference
Bio-effects and safety of low-intensity, low-frequency ultrasonic exposure
10.1016/j.pbiomolbio.2012.01.004 · ExternalCitation · doi-reference
Minimally invasive therapeutic ultrasound: Ultrasound-guided ultrasound ablation in neuro-oncology
10.1016/j.ultras.2020.106210 · ExternalCitation · doi-reference
Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery
10.1016/j.ultrasmedbio.2020.01.002 · ExternalCitation · doi-reference
Focused ultrasound-induced blood–spinal cord barrier opening using short-burst phase-keying exposures in rats: a parameter study
10.1016/j.ultrasmedbio.2021.03.007 · ExternalCitation · doi-reference
The characterization of acoustic cavitation bubbles – An overview
10.1016/j.ultsonch.2010.11.016 · ExternalCitation · doi-reference
Tailoring the size of ultrasound responsive lipid-shelled nanodroplets by varying production parameters and environmental conditions
10.1016/j.ultsonch.2021.105482 · ExternalCitation · doi-reference
Barrier-breaking effects of ultrasonic cavitation for drug delivery and biomarker release
10.1016/j.ultsonch.2023.106346 · ExternalCitation · doi-reference
Progress in application of nanomedicines for enhancing cancer sono-immunotherapy
10.1016/j.ultsonch.2024.107105 · ExternalCitation · doi-reference
Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial
10.1016/s1470-2045(23)00112-2 · ExternalCitation · doi-reference
Focused ultrasound therapy for movement disorders
10.1016/s1474-4422(25)00210-8 · ExternalCitation · doi-reference
Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies
10.1021/acs.bioconjchem.1c00437 · ExternalCitation · doi-reference
Supramolecularly-Cross-Linked Nanogel Assemblies for On-Demand, Ultrasound-Triggered Chemotherapy
10.1021/acs.biomac.3c01432 · ExternalCitation · doi-reference
Ultrasound-augmented mitochondrial calcium ion overload by calcium nanomodulator to induce immunogenic cell death
10.1021/acs.nanolett.0c04778 · ExternalCitation · doi-reference
Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H2O2 and Catalase for Enhanced Radio-Immunotherapy of Cancer
10.1021/acs.nanolett.8b02720 · ExternalCitation · doi-reference
Collagenase-loaded H-TiO2 nanoparticles enhance ultrasound imaging-guided sonodynamic therapy in a pancreatic carcinoma xenograft model via digesting stromal barriers
10.1021/acsami.2c08951 · ExternalCitation · doi-reference
The role of acoustic parameters in droplet vaporization of perfluoropentane nanodroplets for In Vivo applications
10.1021/acsami.5c05638 · ExternalCitation · doi-reference
High intensity focused ultrasound-responsive and ultrastable cerasomal perfluorocarbon nanodroplets for alleviating tumor multidrug resistance and epithelial–mesenchymal transition
10.1021/acsnano.0c07287 · ExternalCitation · doi-reference
Ultrasmall barium titanate nanoparticles for highly efficient hypoxic tumor therapy via ultrasound triggered piezocatalysis and water splitting
10.1021/acsnano.1c00616 · ExternalCitation · doi-reference
Ultrasmall Alloy Nanozyme for Ultrasound- and Near-Infrared Light-Promoted Tumor Ablation
10.1021/acsnano.1c01830 · ExternalCitation · doi-reference
Specific endothelial cells govern nanoparticle entry into solid tumors
10.1021/acsnano.1c04510 · ExternalCitation · doi-reference
Immunosonodynamic Therapy Designed with Activatable Sonosensitizer and Immune Stimulant Imiquimod
10.1021/acsnano.2c03395 · ExternalCitation · doi-reference
Mechanisms and barriers in nanomedicine: progress in the field and future directions
10.1021/acsnano.4c00182 · ExternalCitation · doi-reference
PEGylated Ultrasmall Iron Oxide Nanoparticles as MRI Contrast Agents for Vascular Imaging and Real-Time Monitoring
10.1021/acsnano.4c13356 · ExternalCitation · doi-reference
A Tumor Microenvironment-Responsive Self-Oxygenating Nanoplatform for Dual-Enhanced Cuproptosis and Sonodynamic Synergistic Immunotherapy
10.1021/acsnano.5c12847 · ExternalCitation · doi-reference
A Sonosensitizing Nanoshuttle for Synergistic Hypoxia Relief and Immune Activation To Strengthen Sonodynamic Immunotherapy Against Triple-Negative Breast Cancer
10.1021/acsnano.5c16697 · ExternalCitation · doi-reference
High-Entropy Oxide-Phosphomolybdic Acid Ultrathin Nanoleaves with Lattice Strain and Periodic Heterostructures for Enhanced Synthetic Catalytic/Sonodynamic/Immune Therapy
10.1021/acsnano.6c00143 · ExternalCitation · doi-reference
Ultrasound-Triggered Localized Surface Plasmon Resonance Enhances Electron Transfer for Melanoma Sonodynamic Therapy
10.1021/acsnano.6c04010 · ExternalCitation · doi-reference
Intracellular Photocatalytic NADH/NAD(P)H Oxidation for Cancer Drug Development
10.1021/jacs.4c18328 · ExternalCitation · doi-reference
Cell-cycle dependent nuclear gene delivery enhances the effects of E-cadherin against tumor invasion and metastasis
10.1038/s41392-023-01398-4 · ExternalCitation · doi-reference
Spinal cord injury: molecular mechanisms and therapeutic interventions
10.1038/s41392-023-01477-6 · ExternalCitation · doi-reference
Bio-Barrier-adaptable biomimetic nanomedicines combined with ultrasound for enhanced cancer therapy
10.1038/s41392-025-02217-8 · ExternalCitation · doi-reference
Ultrasound-enhanced Pt-coordinated polymer immunopotentiators and heterogenic fusion membrane-based multifunctional tumor vaccine nanoplatforms for melanoma treatment
10.1038/s41392-025-02355-z · ExternalCitation · doi-reference
Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect
10.1038/s41416-022-02076-y · ExternalCitation · doi-reference
Blood–brain barrier opening in alzheimer’s disease using MR-guided focused ultrasound
10.1038/s41467-018-04529-6 · ExternalCitation · doi-reference
Near-infrared phosphorescent carbon dots for sonodynamic precision tumor therapy
10.1038/s41467-022-33474-8 · ExternalCitation · doi-reference
Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
10.1038/s41467-023-38796-9 · ExternalCitation · doi-reference
Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity
10.1038/s41467-023-39607-x · ExternalCitation · doi-reference
Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity
10.1038/s41467-023-42509-7 · ExternalCitation · doi-reference
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
10.1038/s41467-024-45818-7 · ExternalCitation · doi-reference
Nanobubble-actuated ultrasound neuromodulation for selectively shaping behavior in mice
10.1038/s41467-024-46461-y · ExternalCitation · doi-reference
Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas
10.1038/s41467-024-48326-w · ExternalCitation · doi-reference
Ultrasound-mediated spatial and temporal control of engineered cells in vivo
10.1038/s41467-024-51620-2 · ExternalCitation · doi-reference
Ultrasound-triggered and glycosylation inhibition-enhanced tumor piezocatalytic immunotherapy
10.1038/s41467-024-53392-1 · ExternalCitation · doi-reference
Zn/Pt dual-site single-atom driven difunctional superimposition-augmented sonosensitizer for sonodynamic therapy boosted ferroptosis of cancer
10.1038/s41467-024-53488-8 · ExternalCitation · doi-reference
Synergistic checkpoint-blockade and radiotherapy–radiodynamic therapy via an immunomodulatory nanoscale metal–organic framework
10.1038/s41551-022-00846-w · ExternalCitation · doi-reference
Nanoparticles with Ultrasound-induced afterglow luminescence for tumour-specific theranostics
10.1038/s41551-022-00978-z · ExternalCitation · doi-reference
Acoustically triggered mechanotherapy using genetically encoded gas vesicles
10.1038/s41565-021-00971-8 · ExternalCitation · doi-reference
Cyclic jetting enables microbubble-mediated drug delivery
10.1038/s41567-025-02785-0 · ExternalCitation · doi-reference
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
10.1038/s41568-019-0205-x · ExternalCitation · doi-reference
Clinical development and potential of photothermal and photodynamic therapies for cancer
10.1038/s41571-020-0410-2 · ExternalCitation · doi-reference
Delivery technologies for cancer immunotherapy
10.1038/s41573-018-0006-z · ExternalCitation · doi-reference
Enhancing cancer immunotherapy with nanomedicine
10.1038/s41577-019-0269-6 · ExternalCitation · doi-reference
Drug delivery to the central nervous system
10.1038/s41578-021-00394-w · ExternalCitation · doi-reference
New opportunities and old challenges in the clinical translation of nanotheranostics
10.1038/s41578-023-00581-x · ExternalCitation · doi-reference
Responsive biomaterials: optimizing control of cancer immunotherapy
10.1038/s41578-023-00617-2 · ExternalCitation · doi-reference
H-bonded organic frameworks as ultrasound-programmable delivery platform
10.1038/s41586-024-08401-0 · ExternalCitation · doi-reference
Immunogenic cell stress and death
10.1038/s41590-022-01132-2 · ExternalCitation · doi-reference
Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
10.1038/s41591-023-02345-0 · ExternalCitation · doi-reference
Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood–brain barrier opening
10.1038/s41598-020-75253-9 · ExternalCitation · doi-reference
Characterization of ultrasound-mediated delivery of trastuzumab to normal and pathologic spinal cord tissue
10.1038/s41598-021-83874-x · ExternalCitation · doi-reference
Safety evaluation of a clinical focused ultrasound system for neuronavigation guided blood-brain barrier opening in non-human primates
10.1038/s41598-021-94188-3 · ExternalCitation · doi-reference
Aducanumab delivery via focused ultrasound-induced transient blood–brain barrier opening in vivo
10.1038/s41598-025-02412-1 · ExternalCitation · doi-reference
Effect of microbubble-assisted gemcitabine delivery with repeated ultrasound exposure in a pancreatic cancer organ-on-a-chip model
10.1038/s41598-025-30612-2 · ExternalCitation · doi-reference
Drug transport kinetics of intravascular triggered drug delivery systems
10.1038/s42003-021-02428-z · ExternalCitation · doi-reference
Mechanical forces inducing oxaliplatin resistance in pancreatic cancer can be targeted by autophagy inhibition
10.1038/s42003-024-07268-1 · ExternalCitation · doi-reference
Atomic force microscopy-based mechanobiology
10.1038/s42254-018-0001-7 · ExternalCitation · doi-reference
Biomaterials tools to modulate the tumour microenvironment in immunotherapy
10.1038/s44222-022-00004-6 · ExternalCitation · doi-reference
Engineering photodynamics for treatment, priming and imaging
10.1038/s44222-024-00196-z · ExternalCitation · doi-reference
Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact
10.1038/s44222-024-00203-3 · ExternalCitation · doi-reference
Imaging-guided precision hyperthermia with magnetic nanoparticles
10.1038/s44222-024-00257-3 · ExternalCitation · doi-reference
The synergistic potential of mechanotherapy and sonopermeation to enhance cancer treatment effectiveness
10.1038/s44341-025-00017-3 · ExternalCitation · doi-reference
Redox/ultrasound dual stimuli-responsive nanogel for precisely controllable drug release
10.1039/c8nj00392k · ExternalCitation · doi-reference
Multifunctional sonosensitizers in sonodynamic cancer therapy
10.1039/c9cs00648f · ExternalCitation · doi-reference
Stimuli-responsive dynamic hydrogels: design, properties and tissue engineering applications
10.1039/d3mh00399j · ExternalCitation · doi-reference
Polymeric materials for ultrasound imaging and therapy
10.1039/d3sc04339h · ExternalCitation · doi-reference
Advanced disease therapeutics using engineered living drug delivery systems
10.1039/d4nr05298f · ExternalCitation · doi-reference
Stimuli-responsive nanoplatforms for central nervous system disorders: integrating delivery, modulation, and imaging
10.1039/d5cs01323b · ExternalCitation · doi-reference
Recent advances in acoustic cavitation-inducible materials for cancer sonotheranostics
10.1039/d5nr05210f · ExternalCitation · doi-reference
Ultrasound-activatable transition metal complexes to potentiate sonodynamic therapy
10.1039/d5sc06387f · ExternalCitation · doi-reference
Disrupting the blood–brain barrier by focused ultrasound induces sterile inflammation
10.1073/pnas.1614777114 · ExternalCitation · doi-reference
Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound
10.1073/pnas.1700790114 · ExternalCitation · doi-reference
Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model
10.1073/pnas.1713328114 · ExternalCitation · doi-reference
Microbubble drug conjugate and focused ultrasound blood brain barrier delivery of AAV-2 SIRT-3
10.1080/10717544.2022.2035855 · ExternalCitation · doi-reference
An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy
10.1126/sciadv.adg5964 · ExternalCitation · doi-reference
Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy
10.1136/jitc-2022-006226 · ExternalCitation · doi-reference
Safety and feasibility of repeated and transient blood–brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma
10.1158/1078-0432.ccr-18-3643 · ExternalCitation · doi-reference
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
10.1158/2326-6066.cir-20-0586 · ExternalCitation · doi-reference
First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound
10.1186/2050-5736-2-17 · ExternalCitation · doi-reference
Focused ultrasound on the substantia nigra enables safe neurotensin-polyplex nanoparticle-mediated gene delivery to dopaminergic neurons intranasally and by blood circulation
10.1186/s11671-024-04005-9 · ExternalCitation · doi-reference
Neutrophil-mediated clinical nanodrug for treatment of residual tumor after focused ultrasound ablation
10.1186/s12951-021-01087-w · ExternalCitation · doi-reference
In-situ TiO2-x decoration of titanium carbide MXene for photo/sono-responsive antitumor theranostics
10.1186/s12951-022-01253-8 · ExternalCitation · doi-reference
Biomimetic nanoprobe-augmented triple therapy with photothermal, sonodynamic and checkpoint blockade inhibits tumor growth and metastasis
10.1186/s12951-022-01287-y · ExternalCitation · doi-reference
Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy
10.1186/s12951-022-01453-2 · ExternalCitation · doi-reference
CAFs targeted ultrasound-responsive nanodroplets loaded V9302 and GLULsiRNA to inhibit melanoma growth via glutamine metabolic reprogramming and tumor microenvironment remodeling
10.1186/s12951-023-01979-z · ExternalCitation · doi-reference
Neuromodulation by nanozymes and ultrasound during alzheimer’s disease management
10.1186/s12951-024-02406-7 · ExternalCitation · doi-reference
Endogenous and exogeneous stimuli-triggered reactive oxygen species evoke long-lived carbon monoxide to fight against lung cancer
10.1186/s12951-024-02688-x · ExternalCitation · doi-reference
Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration
10.1186/s12974-021-02337-2 · ExternalCitation · doi-reference
A comparative study of the effects of aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of alzheimer disease
10.1186/s13195-021-00809-4 · ExternalCitation · doi-reference
Therapeutic efficacy of nanoparticles and routes of administration
10.1186/s40824-019-0166-x · ExternalCitation · doi-reference
Assessment of neck muscle thickness and stiffness in Chinese healthy individuals by ultrasound
10.21037/qims-2025-435 · ExternalCitation · doi-reference
Clinical study of ultrasound and microbubbles for enhancing chemotherapeutic sensitivity of malignant tumors in digestive system
10.21147/j.issn.1000-9604.2018.05.09 · ExternalCitation · doi-reference
Nerve growth factor delivery by ultrasound-mediated nanobubble destruction as a treatment for acute spinal cord injury in rats
10.2147/ijn.s128848 · ExternalCitation · doi-reference
Nanomedicines Reshape the Tumor Microenvironment: Multidimensional Strategies from Modulating ″Barriers″ to Metabolic Intervention
10.2147/ijn.s570411 · ExternalCitation · doi-reference
Smart Ultrasound-responsive Polymers for Drug Delivery: An Overview on Advanced Stimuli-sensitive Materials and Techniques
10.2174/0115672018283792240115053302 · ExternalCitation · doi-reference
Advanced Ultrasound Technologies for Diagnosis and Therapy
10.2967/jnumed.117.200030 · ExternalCitation · doi-reference
Ultrasound-mediated micellar drug delivery
10.3109/02656736.2012.665567 · ExternalCitation · doi-reference
Supercritical Fluids: An Innovative Strategy for Drug Development
10.3390/bioengineering11080788 · ExternalCitation · doi-reference
Recent advances in strategies for addressing hypoxia in tumor photodynamic therapy
10.3390/biom12010081 · ExternalCitation · doi-reference
Programming Pluripotent Precursor Cells Derived from Xenopus Embryos to Generate Specific Tissues and Organs
10.3390/genes1030413 · ExternalCitation · doi-reference
Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints
10.3390/ijms23031711 · ExternalCitation · doi-reference
Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor
10.3390/pharmaceutics13010015 · ExternalCitation · doi-reference
Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment
10.3390/pharmaceutics13081295 · ExternalCitation · doi-reference
Ultrasound-responsive liposomes for targeted drug delivery combined with focused ultrasound
10.3390/pharmaceutics14071314 · ExternalCitation · doi-reference
Large-Volume Focused-Ultrasound Mild Hyperthermia for Improving Blood-Brain Tumor Barrier Permeability Application
10.3390/pharmaceutics14102012 · ExternalCitation · doi-reference
Disruption of the blood-spinal cord barrier using low-intensity focused ultrasound in a rat model
10.3791/65113 · ExternalCitation · doi-reference
Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape
10.4049/jimmunol.1500541 · ExternalCitation · doi-reference
Magnetic resonance imaging-guided focused ultrasound to increase localized blood-spinal cord barrier permeability
10.4103/1673-5374.221162 · ExternalCitation · doi-reference
Progress of research in the application of ultrasound technology for the treatment of Alzheimer’s disease
10.4103/nrr.nrr-d-24-00539 · ExternalCitation · doi-reference
Biomimetic piezoelectric hydrogel system for energy metabolism reprogramming in spinal cord injury repair
10.7150/thno.108329 · ExternalCitation · doi-reference
Sono-piezoelectric cues regulate neuroinflammatory reflex-arc-mediated α7nAChR-P2RX7 axis to dampen osteoarthritis-correlated pain with osteoarthritis attenuation
10.7150/thno.125686 · ExternalCitation · doi-reference
Unilateral Focused Ultrasound-Induced Blood-Brain Barrier Opening Reduces Phosphorylated Tau from The rTg4510 Mouse Model
10.7150/thno.28717 · ExternalCitation · doi-reference
A porcine model of transvertebral ultrasound and microbubble-mediated blood-spinal cord barrier opening
10.7150/thno.46821 · ExternalCitation · doi-reference
Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity
10.7150/thno.52436 · ExternalCitation · doi-reference
Closed-loop trans-skull ultrasound hyperthermia leads to improved drug delivery from thermosensitive drugs and promotes changes in vascular transport dynamics in brain tumors
10.7150/thno.54630 · ExternalCitation · doi-reference
Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation
10.7150/thno.62572 · ExternalCitation · doi-reference
A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy
10.7150/thno.64862 · ExternalCitation · doi-reference
Engineered extracellular vesicle-based sonotheranostics for dual stimuli-sensitive drug release and photoacoustic imaging-guided chemo-sonodynamic cancer therapy
10.7150/thno.65516 · ExternalCitation · doi-reference
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy
10.7150/thno.69682 · ExternalCitation · doi-reference
A sporadic Alzheimer’s blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies
10.7150/thno.72685 · ExternalCitation · doi-reference
Transcranial blood-brain barrier opening in alzheimer’s disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping
10.7150/thno.94206 · ExternalCitation · doi-reference
Bioeffects Committee of the American Institute of Ultrasound in, M. Overview of Therapeutic Ultrasound Applications and Safety Considerations
10.7863/jum.2012.31.4.623 · ExternalCitation · doi-reference